| Dr Bradley Clifford Christ, MD | |
|
3901 Capital Mall Dr Sw, Ste A, Olympia, WA 98502-8654 | |
| (360) 491-8439 | |
| (360) 491-6328 |
| Full Name | Dr Bradley Clifford Christ |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 14 Years |
| Location | 3901 Capital Mall Dr Sw, Olympia, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659675684 | NPI | - | NPPES |
| 2063539 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD60668500 (Washington) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Providence St Peter Hospital | Olympia, WA | Hospital |
| Mason General Hospital & Family Of Clinics | Shelton, WA | Hospital |
| Summit Pacific Medical Center-swing Bed Unit | Elma, WA | Hospital |
| Grays Harbor Community Hospital | Aberdeen, WA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Olympia Orthopaedic Associates, Pllc | 2365337508 | 79 |
News Archive
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista® (raloxifene HCl tablets) are valid. These patents provide protection for Evista in the U.S. through March of 2014.
Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, type 2 diabetes, obesity and cognitive decline, and infections.
Treatments that ramp up production of the tiny "motors" that power cells may have promise for treating one of the most common forms of inherited neuromuscular disease, according to a report in the September Cell Metabolism, a Cell Press publication. Neuromuscular disorders caused by defects in those mitochondrial motors affect a large number of children and adults worldwide, but today remain without treatment, the researchers said.
Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.
› Verified 8 days ago
| Entity Name | Olympia Orthopaedic Associates, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083785398 PECOS PAC ID: 2365337508 Enrollment ID: O20040217001032 |
News Archive
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista® (raloxifene HCl tablets) are valid. These patents provide protection for Evista in the U.S. through March of 2014.
Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, type 2 diabetes, obesity and cognitive decline, and infections.
Treatments that ramp up production of the tiny "motors" that power cells may have promise for treating one of the most common forms of inherited neuromuscular disease, according to a report in the September Cell Metabolism, a Cell Press publication. Neuromuscular disorders caused by defects in those mitochondrial motors affect a large number of children and adults worldwide, but today remain without treatment, the researchers said.
Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.
› Verified 8 days ago
| Entity Name | Public Hospital District No 1 Of Mason County |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760568752 PECOS PAC ID: 0345139275 Enrollment ID: O20040310001481 |
News Archive
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista® (raloxifene HCl tablets) are valid. These patents provide protection for Evista in the U.S. through March of 2014.
Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, type 2 diabetes, obesity and cognitive decline, and infections.
Treatments that ramp up production of the tiny "motors" that power cells may have promise for treating one of the most common forms of inherited neuromuscular disease, according to a report in the September Cell Metabolism, a Cell Press publication. Neuromuscular disorders caused by defects in those mitochondrial motors affect a large number of children and adults worldwide, but today remain without treatment, the researchers said.
Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Bradley Clifford Christ, MD Po Box 368, Olympia, WA 98507-0368 Ph: (360) 491-8439 | Dr Bradley Clifford Christ, MD 3901 Capital Mall Dr Sw, Ste A, Olympia, WA 98502-8654 Ph: (360) 491-8439 |
News Archive
Eli Lilly and Company today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed a prior ruling by the U.S. District Court for the Southern District of Indiana that the company's method-of-use patents for Evista® (raloxifene HCl tablets) are valid. These patents provide protection for Evista in the U.S. through March of 2014.
Vitamin D is recognized as an important co-factor in several physiological processes linked with bone and calcium metabolism, and also in diverse non-skeletal outcomes, including autoimmune diseases, cardiovascular diseases, type 2 diabetes, obesity and cognitive decline, and infections.
Treatments that ramp up production of the tiny "motors" that power cells may have promise for treating one of the most common forms of inherited neuromuscular disease, according to a report in the September Cell Metabolism, a Cell Press publication. Neuromuscular disorders caused by defects in those mitochondrial motors affect a large number of children and adults worldwide, but today remain without treatment, the researchers said.
Heart valve replacements made from tissue (bioprosthetic valves) have long been thought to be spared the complication of blood clot formation. Researchers have now found that about 15 percent of all bioprosthetic aortic heart valve patients develop blood clots on the leaflets affecting valve opening, regardless of whether the patient received the new valve via open-heart surgery or a minimally-invasive catheter procedure, a new study from the Cedars-Sinai Heart Institute shows.
› Verified 8 days ago
Dr. Milan Shannon Moore, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Capital Mall Dr Sw Ste A, Olympia, WA 98502 Phone: 360-786-8990 Fax: 360-786-9010 | |
Dr. Patrick J. Halpin, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3901 Capital Mall Dr Sw, Ste A, Olympia, WA 98502 Phone: 360-786-8990 Fax: 360-786-9010 | |
Richard Joseph Lamour, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 615 Lilly Rd Ne Ste 100, Olympia, WA 98506 Phone: 360-491-8439 Fax: 360-491-6328 | |
Dr. Ryan William Hadden, M.D. Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3901 Capital Mall Dr Sw Ste A, Olympia, WA 98502 Phone: 360-570-3460 Fax: 360-786-9010 | |
Dr. Timothy Albert Dumontier, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Capital Mall Dr Sw, Ste A, Olympia, WA 98502 Phone: 360-455-5144 Fax: 360-491-6328 | |
Dr. Clyde T. Carpenter, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 3901 Capital Mall Dr Sw, Ste A, Olympia, WA 98502 Phone: 360-786-8990 Fax: 360-786-9010 | |
Dr. Dennis Smith, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 615 Lilly Rd Ne, Suite 100, Olympia, WA 98506 Phone: 360-491-4211 Fax: 360-493-0407 |